Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

As current weight loss medications like Ozempic, Wegovy, and Zepbound face persistent supply challenges and accessibility issues, breakthrough research into cellular metabolism offers hope for a ...

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...

which could be a concern for those interested in Zepbound. A spokesperson from Eli Lilly addressed this issue. “Today we are able to meet demand, but realize we will face challenges. We do our ...

Zepbound is a medicine you can obtain only by prescription, and it's typically used to address obesity and other ...

Patients face ongoing roadblocks to getting prescriptions ... according to its producer, Novo Nordisk. Zepbound costs more than $1,000, according to maker Eli Lilly. Pharmaceutical companies ...